| Year |
Title |
Altmetric |
| 2019
|
A blood-based signature of cerebrospinal fluid Aβ 1–42 status.
Scientific Reports.
9.
2019
|
|
| 2019
|
Comparison of Pittsburgh compound B and florbetapir in cross-sectional and longitudinal studies.
Alzheimer's && Dementia :: Diagnosis, Assessment && Disease Monitoring.
11:180-190.
2019
|
|
| 2019
|
Predicting Short-term MCI-to-AD Progression Using Imaging, CSF, Genetic Factors, Cognitive Resilience, and Demographics.
Scientific Reports.
9.
2019
|
|
| 2019
|
Reduction of microglial progranulin does not exacerbate pathology or behavioral deficits in neuronal progranulin-insufficient mice.
Neurobiology of Disease.
124:152-162.
2019
|
|
| 2019
|
Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing.
Nature Genetics.
51:414-430.
2019
|
|
| 2019
|
Severity dependent distribution of impairments in PSP and CBS: Interactive visualizations.
Parkinsonism and Related Disorders.
60:138-145.
2019
|
|
| 2019
|
Nicastrin haploinsufficiency alters expression of type I interferon-stimulated genes: the relationship to familial hidradenitis suppurativa.
Clinical and Experimental Dermatology.
2019
|
|
| 2018
|
Brain multiplexes reveal morphological connectional biomarkers fingerprinting late brain dementia states.
Scientific Reports.
8.
2018
|
|
| 2018
|
Characteristic patterns of inter- and intra-hemispheric metabolic connectivity in patients with stable and progressive mild cognitive impairment and Alzheimer’s disease.
Scientific Reports.
8.
2018
|
|
| 2018
|
Multimodal and Multiscale Deep Neural Networks for the Early Diagnosis of Alzheimer’s Disease using structural MR and FDG-PET images.
Scientific Reports.
8.
2018
|
|
| 2018
|
Sex-specific genetic predictors of Alzheimer’s disease biomarkers.
Acta Neuropathologica.
136:857-872.
2018
|
|
| 2018
|
Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with Subtype and Stage Inference.
Nature Communications.
9.
2018
|
|
| 2018
|
Sex-specific association of apolipoprotein e with cerebrospinal fluid levels of tau.
JAMA Neurology.
75:989-998.
2018
|
|
| 2018
|
Partial Tmem106b reduction does not correct abnormalities due to progranulin haploinsufficiency.
Molecular Neurodegeneration.
13.
2018
|
|
| 2018
|
Shared Functions of Perirhinal and Parahippocampal Cortices: Implications for Cognitive Aging.
Trends in Neurosciences.
41:349-359.
2018
|
|
| 2018
|
Progranulin gene therapy improves lysosomal dysfunction and microglial pathology associated with frontotemporal dementia and neuronal ceroid lipofuscinosis.
Journal of Neuroscience.
38:2341-2358.
2018
|
|
| 2018
|
18F-florbetapir Positron Emission Tomography-determined Cerebral β-Amyloid Deposition and Neurocognitive Performance after Cardiac Surgery..
Anesthesiology.
128:728-744.
2018
|
|
| 2018
|
Medical decision-making in progressive supranuclear palsy: A comparison to other neurodegenerative disorders.
Parkinsonism and Related Disorders.
2018
|
|
| 2018
|
Regional Amyloid-β Load and White Matter Abnormalities Contribute to Hypometabolism in Alzheimer’s Dementia.
Molecular Neurobiology.
2018
|
|
| 2017
|
Cascaded Multi-view Canonical Correlation (CaMCCo) for Early Diagnosis of Alzheimer's Disease via Fusion of Clinical, Imaging and Omic Features.
Scientific Reports.
7.
2017
|
|
| 2017
|
Genetic influences on cognition in progressive supranuclear palsy.
Movement Disorders.
32:1764-1771.
2017
|
|
| 2017
|
Pattern Discovery in Brain Imaging Genetics via SCCA Modeling with a Generic Non-convex Penalty.
Scientific Reports.
7.
2017
|
|
| 2017
|
18F-flortaucipir tau positron emission tomography distinguishes established progressive supranuclear palsy from controls and Parkinson disease: A multicenter study.
Annals of Neurology.
82:622-634.
2017
|
|
| 2017
|
Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease.
Nature Genetics.
49:1373-1384.
2017
|
|
| 2017
|
Transethnic genome-wide scan identifies novel Alzheimer's disease loci.
Alzheimer's and Dementia.
13:727-738.
2017
|
|
| 2017
|
Holocranohistochemistry enables the visualization of α-synuclein expression in the murine olfactory system and discovery of its systemic anti-microbial effects.
Journal of Neural Transmission.
124:721-738.
2017
|
|
| 2017
|
Association of plasma neurofilament light with neurodegeneration in patients with Alzheimer disease.
JAMA Neurology.
74:557-566.
2017
|
|
| 2017
|
Restoring neuronal progranulin reverses deficits in a mouse model of frontotemporal dementia.
Brain.
140:1447-1465.
2017
|
|
| 2017
|
Longitudinal measurement and hierarchical classification framework for the prediction of Alzheimer's disease.
Scientific Reports.
7.
2017
|
|
| 2017
|
Clinical, imaging, pathological, and biochemical characterization of a novel presenilin 1 mutation (N135Y) causing Alzheimer's disease.
Neurobiology of Aging.
49:216.e7.
2017
|
|
| 2016
|
Incidence and impact of subclinical epileptiform activity in Alzheimer's disease.
Annals of Neurology.
80:858-870.
2016
|
|
| 2016
|
Minimal clinically important worsening on the progressive supranuclear Palsy Rating Scale.
Movement Disorders.
31:1574-1577.
2016
|
|
| 2016
|
Clinical correlates of longitudinal brain atrophy in progressive supranuclear palsy.
Parkinsonism and Related Disorders.
28:29-35.
2016
|
|
| 2016
|
Predicting disease progression in progressive supranuclear palsy in multicenter clinical trials.
Parkinsonism and Related Disorders.
28:41-48.
2016
|
|
| 2016
|
Progranulin haploinsufficiency causes biphasic social dominance abnormalities in the tube test.
Genes, Brain and Behavior.
15:588-603.
2016
|
|
| 2016
|
Early role of vascular dysregulation on late-onset Alzheimer's disease based on multifactorial data-driven analysis.
Nature Communications.
7.
2016
|
|
| 2016
|
Association between anticholinergic medication use and cognition, brain metabolism, and brain atrophy in cognitively normal older adults.
JAMA Neurology.
73:721-732.
2016
|
|
| 2016
|
Assessment of the genetic variance of late-onset Alzheimer's disease.
Neurobiology of Aging.
41:200.e13-200.e20.
2016
|
|
| 2016
|
Power calculations and placebo effect for future clinical trials in progressive supranuclear palsy.
Movement Disorders.
31:742-747.
2016
|
|
| 2016
|
Alzheimer's disease risk polymorphisms regulate gene expression in the ZCWPW1 and the CELF1 loci.
PLoS ONE.
11.
2016
|
|
| 2016
|
A novel Alzheimer disease locus located near the gene encoding tau protein.
Molecular Psychiatry.
21:108-117.
2016
|
|
| 2015
|
Genetically predicted body mass index and Alzheimer's disease-related phenotypes in three large samples: Mendelian randomization analyses.
Alzheimer's and Dementia.
11:1439-1451.
2015
|
|
| 2015
|
The Alzheimer's disease risk factor CD2AP maintains blood-brain barrier integrity.
Human Molecular Genetics.
24:6667-6674.
2015
|
|
| 2015
|
Vascular amyloidosis impairs the gliovascular unit in a mouse model of Alzheimer's disease.
Brain.
138:3716-3733.
2015
|
|
| 2015
|
Association of long runs of homozygosity with Alzheimer disease among African American individuals.
JAMA Neurology.
72:1313-1323.
2015
|
|
| 2015
|
Associations between Potentially Modifiable Risk Factors and Alzheimer Disease: A Mendelian Randomization Study.
PLoS Medicine.
12.
2015
|
|
| 2015
|
Ferritin levels in the cerebrospinal fluid predict Alzheimer's disease outcomes and are regulated by APOE.
Nature Communications.
6.
2015
|
|
| 2015
|
Effects of exercise on progranulin levels and gliosis in progranulin-insufficient mice.
eNeuro.
2.
2015
|
|
| 2015
|
Early-onset lymphoproliferation and autoimmunity caused by germline STAT3 gain-of-function mutations.
Blood.
125:591-599.
2015
|
|
| 2015
|
Noradrenergic dysfunction in Alzheimer's disease.
Frontiers in Neuroscience.
9.
2015
|
|
| 2015
|
Rarity of the alzheimer disease-protective APP A673T variant in the United States.
JAMA Neurology.
72:209-216.
2015
|
|
| 2015
|
Tau-dependent Kv4.2 depletion and dendritic hyperexcitability in a mouse model of Alzheimer’s disease.
Journal of Neuroscience.
35:6221-6230.
2015
|
|
| 2014
|
Tau-mediated NMDA receptor impairment underlies dysfunction of a selectively vulnerable network in a mouse model of frontotemporal dementia.
Journal of Neuroscience.
34:16482-16495.
2014
|
|
| 2014
|
Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: A genome-wide association study.
JAMA Neurology.
71:1394-1404.
2014
|
|
| 2014
|
ALS-associated mutation FUS-R521C causes DNA damage and RNA splicing defects.
Journal of Clinical Investigation.
124:981-999.
2014
|
|
| 2014
|
AlphaScreen HTS and live-cell bioluminescence resonance energy transfer (bret) assays for identification of Tau-Fyn sh3 interaction inhibitors for Alzheimer disease.
Journal of Biomolecular Screening.
19:1338-1349.
2014
|
|
| 2014
|
Davunetide in patients with progressive supranuclear palsy: A randomised, double-blind, placebo-controlled phase 2/3 trial.
Lancet Neurology.
13:676-685.
2014
|
|
| 2014
|
Early retinal neurodegeneration and impaired Ran-mediated nuclear import of TDP-43 in progranulin-deficient FTLD.
Journal of Experimental Medicine.
211:1937-1945.
2014
|
|
| 2014
|
Seizure resistance without parkinsonism in aged mice after tau reduction.
Neurobiology of Aging.
35:2617-2624.
2014
|
|
| 2014
|
The dendritic hypothesis for Alzheimer's disease pathophysiology.
Brain Research Bulletin.
103:18-28.
2014
|
|
| 2013
|
Dissociation of frontotemporal dementia-related deficits and neuroinflammation in progranulin haploinsufficient mice.
Annals of Internal Medicine.
158:5352-5362.
2013
|
|
| 2013
|
Amyloid-β signals through tau to drive ectopic neuronal cell cycle re-entry in alzheimer's disease.
Journal of Cell Science.
126:1278-1286.
2013
|
|
| 2013
|
Frontotemporal degeneration, the next therapeutic frontier: Molecules and animal models for frontotemporal degeneration drug development.
Alzheimer's and Dementia.
9:176-188.
2013
|
|
| 2013
|
The advantages of frontotemporal degeneration drug development (part 2 of frontotemporal degeneration: The next therapeutic frontier).
Alzheimer's and Dementia.
9:189-198.
2013
|
|
| 2012
|
Challenges and opportunities for characterizing cognitive aging across species.
Frontiers in Aging Neuroscience.
4.
2012
|
|
| 2012
|
Common genetic variants in the CLDN2 and PRSS1-PRSS2 loci alter risk for alcohol-related and sporadic pancreatitis.
Nature Genetics.
44:1349-1354.
2012
|
|
| 2012
|
Mouse models of frontotemporal dementia.
Annals of Neurology.
72:837-849.
2012
|
|
| 2012
|
Usp14 Deficiency Increases Tau Phosphorylation without Altering Tau Degradation or Causing Tau-Dependent Deficits.
PLoS ONE.
7.
2012
|
|
| 2012
|
Mouse models of Alzheimer's disease.
Brain Research Bulletin.
88:3-12.
2012
|
|
| 2012
|
Evidence for a role of the rare p.A152T variant in mapt in increasing the risk for FTD-spectrum and Alzheimer's diseases.
Human Molecular Genetics.
21:3500-3512.
2012
|
|
| 2011
|
Geriatric epilepsy: Research and clinical directions for the future.
Epilepsy and Behavior.
22:103-111.
2011
|
|
| 2011
|
Contemporary approaches to Alzheimer's disease and frontotemporal dementia..
Methods in Molecular Biology.
670:1-9.
2011
|
|
| 2011
|
Quantifying biomarkers of cognitive dysfunction and neuronal network hyperexcitability in mouse models of Alzheimer's disease: depletion of calcium-dependent proteins and inhibitory hippocampal remodeling..
Methods in Molecular Biology.
670:245-262.
2011
|
|
| 2011
|
Step-by-step in situ hybridization method for localizing gene expression changes in the brain..
Methods in Molecular Biology.
670:207-230.
2011
|
|
| 2011
|
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.
Nature Genetics.
43:436-443.
2011
|
|
| 2011
|
Amyloid-β/fyn-induced synaptic, network, and cognitive impairments depend on tau levels in multiple mouse models of alzheimer's disease.
Journal of Neuroscience.
31:700-711.
2011
|
|
| 2011
|
Contemporary approaches to Alzheimer's disease and frontotemporal dementia.
Methods in Molecular Biology.
670:1-9.
2011
|
|
| 2011
|
Quantifying biomarkers of cognitive dysfunction and neuronal network hyperexcitability in mouse models of Alzheimer's disease: Depletion of calcium-dependent proteins and inhibitory hippocampal remodeling.
Methods in Molecular Biology.
670:245-262.
2011
|
|
| 2011
|
Step-by-step in situ hybridization method for localizing gene expression changes in the brain.
Methods in Molecular Biology.
670:207-230.
2011
|
|
| 2009
|
Loss of Hsp70 exacerbates pathogenesis but not levels of fibrillar aggregates in a mouse model of Huntington's disease.
Journal of Neuroscience.
29:9104-9114.
2009
|
|
| 2008
|
Enkephalin elevations contribute to neuronal and behavioral impairments in a transgenic mouse model of Alzheimer's disease.
Journal of Neuroscience.
28:5007-5017.
2008
|
|
| 2008
|
Abnormal social behaviors in mice lacking Fgf17.
Genes, Brain and Behavior.
7:344-354.
2008
|
|
| 2007
|
Aberrant Excitatory Neuronal Activity and Compensatory Remodeling of Inhibitory Hippocampal Circuits in Mouse Models of Alzheimer's Disease.
Neuron.
55:697-711.
2007
|
|
| 2007
|
Reducing endogenous tau ameliorates amyloid β-induced deficits in an Alzheimer's disease mouse model.
Science.
316:750-754.
2007
|
|
| 2006
|
100 Years and counting: Prospects for defeating Alzheimer's disease.
Science.
314:781-784.
2006
|
|
| 2006
|
Frontotemporal demetia.
Current Neurology and Neuroscience Reports.
6:481-489.
2006
|
|
| 2006
|
Antiamyloidogenic and Neuroprotective Functions of Cathepsin B: Implications for Alzheimer's Disease.
Neuron.
51:703-714.
2006
|
|
| 2005
|
Frontotemporal dementia progresses to death faster than Alzheimer disease.
Neurology.
65:719-725.
2005
|
|
| 2005
|
Frontotemporal lobar degeneration: Demographic characteristics of 353 patients.
Archives of Neurology -Chigago-.
62:925-930.
2005
|
|
| 2003
|
Polyneuropathy following gastric bypass surgery [6].
American Journal of Medicine.
115:679-680.
2003
|
|
| 2001
|
Memory-forming chemical reactions.
Reviews in the Neurosciences.
12:41-50.
2001
|
|
| 2000
|
MAPK regulation of gene expression in the central nervous system.
Acta Neurobiologiae Experimentalis.
60:377-394.
2000
|
|
| 1999
|
A biochemical blueprint for long-term memory.
Learning and Memory.
6:381-388.
1999
|
|
| 1999
|
The mitogen-activated protein kinase cascade couples PKA and PKC to cAMP response element binding protein phosphorylation in area CA1 of hippocampus.
Journal of Neuroscience.
19:4337-4348.
1999
|
|
| 1998
|
Protected-site phosphorylation of protein kinase C in hippocampal long- term potentiation.
Journal of Neurochemistry.
71:1075-1085.
1998
|
|
| 1998
|
Mice lacking ataxin-1 display learning deficits and decreased hippocampal paired-pulse facilitation.
Journal of Neuroscience.
18:5508-5516.
1998
|
|
| 1998
|
A role for superoxide in protein kinase C activation and induction of long-term potentiation.
Journal of Biological Chemistry.
273:4516-4522.
1998
|
|
| 1996
|
Transient activation of cyclic AMP-dependent protein kinase during hippocampal long-term potentiation.
Journal of Biological Chemistry.
271:30436-30441.
1996
|
|
| 1996
|
A biochemist's view of long-term potentiation.
Learning and Memory.
3:1-24.
1996
|
|
| 1995
|
Regulation of adenylyl cyclase in LTP.
Behavioral and Brain Sciences.
18:485-486.
1995
|
|
| 1992
|
Ca2+-induced persistent protein kinase C activation in rat hippocampal homogenates.
Journal of receptor research.
14:109-126.
1992
|
|
| 1988
|
Identification of an insulin-like factor in astrocyte conditioned medium.
Brain Research.
460:60-67.
1988
|
|
